Annual Report 2022

39 China Merchants China Direct Investments Limited Annual Report 2022 INVESTMENT MANAGER’S DISCUSSION AND ANALYSIS (CONTINUED) SUB-PARTICIPATION SCHEME (CONTINUED) Name of projects Mr. ZHOU Xing Mr. ZHANG Rizhong Mr. WANG Xiaoding Mr. TSE Yue Kit Mr. KANG Dong (Note 1) (Note 2) (Note 3) (Note 4) (Note 5) US$ US$ US$ US$ US$ Flexiv N/A 1,290 20,460 1,290 N/A Huashun Xin’an (1st installment capital contribution for 1st round capital injection) N/A 1,030 1,030 1,030 N/A Huashun Xin’an (2nd installment capital contribution for 1st round capital injection) N/A 260 260 260 N/A Huiyou Xingyao Fund (2nd installment capital contribution) N/A 830 410 410 N/A CASREV Fund III (3rd installment capital contribution) N/A 320 320 320 N/A Xinyi N/A 6,430 1,290 1,290 N/A iFlyHealth (2nd round capital injection) N/A N/A 1,280 N/A 1,280 Azuri N/A N/A 1,280 N/A 1,280 Huashun Xin’an (2nd round capital injection) N/A N/A 1,270 N/A 1,270 CASREV Fund III (4th installment capital contribution) N/A 320 320 320 N/A Immvira N/A N/A 1,270 N/A 1,270 Note 1: The Chairman of the Fund Note 2: Director of the Fund and Chairman of the Investment Manager Note 3: Director of the Fund and Director & General Manager of the Investment Manager Note 4: Director of the Fund and Director of the Investment Manager Note 5: Director of the Investment Manager Mr. WANG Xiaoding Director & General Manager China Merchants China Investment Management Limited Hong Kong, 28 March 2023